<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">systhiper</journal-id><journal-title-group><journal-title xml:lang="ru">Системные гипертензии</journal-title><trans-title-group xml:lang="en"><trans-title>Systemic Hypertension</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2075-082X</issn><issn pub-type="epub">2542-2189</issn><publisher><publisher-name>LLC «ИнтерМедсервис»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26442/2075082X.2020.3.200334</article-id><article-id custom-type="elpub" pub-id-type="custom">systhiper-606</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНАЯ СТАТЬЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLE</subject></subj-group></article-categories><title-group><article-title>Метод спекл-трекинг эхокардиографии в 3D-режиме в оценке деформационных свойств миокарда и выявлении субклинической кардиотоксичности при химиотерапии у больных раком молочной железы с артериальной гипертонией</article-title><trans-title-group xml:lang="en"><trans-title>Speckle-tracking echocardiography in 3D mode in assessing the deformation of the myocardium and identifying subclinical cardiotoxicity during chemotherapy in breast cancer patients with arterial hypertension</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0442-4495</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Авалян</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Avalyan</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">ani_avalian@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3233-1862</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Саидова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Saidova</surname><given-names>M. A.</given-names></name></name-alternatives><email xlink:type="simple">ani_avalian@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3253-0669</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ощепкова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Oshchepkova</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">ani_avalian@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9822-4357</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чазова</surname><given-names>И. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Chazova</surname><given-names>I. E.</given-names></name></name-alternatives><email xlink:type="simple">c34h@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр кардиологии» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center for Cardiology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>23</day><month>12</month><year>2022</year></pub-date><volume>17</volume><issue>3</issue><fpage>42</fpage><lpage>47</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Авалян А.А., Саидова М.А., Ощепкова Е.В., Чазова И.Е., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Авалян А.А., Саидова М.А., Ощепкова Е.В., Чазова И.Е.</copyright-holder><copyright-holder xml:lang="en">Avalyan A.A., Saidova M.A., Oshchepkova E.V., Chazova I.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.syst-hypertension.ru/jour/article/view/606">https://www.syst-hypertension.ru/jour/article/view/606</self-uri><abstract><p>Цель. Изучить возможности технологии спекл-трекинг эхокардиографии (СТЭ) в режиме 3D в оценке деформационных свойств миокарда и выявлении субклинической кардиотоксичности при антрациклинсодержащей химиотерапии у больных раком молочной железы (РМЖ) с артериальной гипертонией (АГ). Материалы и методы. В исследование включены 47 больных тройным негативным РМЖ с АГ и нормотензией. Всем участникам исследования проводилась трансторакальная эхокардиография (ЭхоКГ) с оценкой фракции выброса левого желудочка (ЛЖ), также применялась технология СТЭ в трехмерном режиме с оценкой глобальной продольной (global longitudinal strain - GLS), циркулярной (global circumferential strain - GСS), радиальной (global radial strain - GRS) деформаций ЛЖ и нового параметра деформации - площади деформации (global area strain - GAS). Результаты. В проведенной работе продемонстрировано, что у больных РМЖ для более точной оценки систолической функции ЛЖ целесообразно применение 3D-ЭхоКГ. У больных РМЖ с АГ исходно показатели деформации ЛЖ статистически значимо хуже по сравнению с больными с нормотензией, и после химиотерапии наблюдалось дальнейшее ухудшение. Для определения чувствительности и специфичности параметров деформации по данным 3D-СТЭ проведен ROC-анализ. Наиболее диагностически значимым параметром деформации как маркера кардиотоксичности оказался новый показатель GAS, который при отрезном значении ≥-14,0% показал чувствительность, равную 81,5%, и специфичность - 73,3%, однако значение данного параметра деформации ЛЖ требует дальнейшего изучения. Заключение. У больных РМЖ как с АГ, так и с нормотензией целесообразно применение метода СТЭ в режиме 3D для анализа деформационных свойств и систолической функции ЛЖ при проведении противоопухолевого лечения. Метод перспективен для выявления субклинической кардиотоксичности, но нужны дальнейшие исследования по разработке диагностических критериев.</p></abstract><trans-abstract xml:lang="en"><p>Aim. To study the possibilities of speckle-tracking echocardiography (STE) in 3D mode in assessing the strain of the myocardium and identifying subclinical cardiotoxicity during anthracycline-containing chemotherapy in breast cancer patients with arterial hypertension. Materials and methods. The study included 47 patients with triple negative breast cancer (BC) with AH and normotension. All patients underwent transthoracic echocardiography with an assessment of the left ventricular (LV) ejection fraction, also used STE in three-dimensional mode with an assessment of global longitudinal (GLS), circular (GCS), radial (GRS) strain and a new strain parameter - strain area (GAS). Results. In patients with BC for a more accurate assessment of LV systolic function, it is advisable to use 3D echocardiography. In BC patients with AH, the initial parameters of LV strain were statistically significantly worse than in patients with normotension and further deterioration was observed after chemotherapy. To determine the sensitivity and specificity of the strain parameters from the 3D-STE data, an ROC analysis was performed. The most diagnostically significant parameter of strain, as a marker of cardiotoxicity, was the global area strain (GAS), which with a cut-off value ≥-14.0% showed a sensitivity equal to 81.5% and a specificity of 73.3%, but the value this parameter of LV deformation requires further study. Conclusion. In BC patients with AH and normotension it is advisable to use the STE in 3D mode to analyze the strain and systolic function of the LV during antitumor treatment. The method is promising for identifying subclinical cardiotoxicity, but further research is needed to develop diagnostic criteria.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>спекл-трекинг эхокардиография в трехмерном режиме</kwd><kwd>кардиотоксичность</kwd><kwd>химиотерапия</kwd><kwd>рак молочной железы</kwd><kwd>артериальная гипертония</kwd></kwd-group><kwd-group xml:lang="en"><kwd>speckle-tracking echocardiography in three-dimensional mode</kwd><kwd>cardiotoxicity</kwd><kwd>chemotherapy</kwd><kwd>breast cancer</kwd><kwd>arterial hypertension</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Unitt C, Montazeri K, Tolaney S, Moslehi J. Cardiology patient page: breast cancer chemotherapy and your heart. Circulation 2014; 129 (25): 680-2.</mixed-citation><mixed-citation xml:lang="en">Unitt C, Montazeri K, Tolaney S, Moslehi J. Cardiology patient page: breast cancer chemotherapy and your heart. Circulation 2014; 129 (25): 680-2.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Florescu M, Cinteza M, Vinereanu D. Chemotherapy-induced Cardiotoxicity. Maedica - J Clin Med 2013; 8 (1): 59-67.</mixed-citation><mixed-citation xml:lang="en">Florescu M, Cinteza M, Vinereanu D. Chemotherapy-induced Cardiotoxicity. Maedica - J Clin Med 2013; 8 (1): 59-67.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Yuand Jones. Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasures. Cardio-Oncol 2016; 2: 1-15.</mixed-citation><mixed-citation xml:lang="en">Yuand Jones. Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasures. Cardio-Oncol 2016; 2: 1-15.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Force T, Kolaja KL. Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes. Nat Rev Drug Dis 2011; 10: 111-26.</mixed-citation><mixed-citation xml:lang="en">Force T, Kolaja KL. Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes. Nat Rev Drug Dis 2011; 10: 111-26.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Zamorano JL, Lancellotti P, Rodriguez Muñoz D et al. 2016 ESC Position Paper on cancer treatment and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J 2016; 37: 2768-801.</mixed-citation><mixed-citation xml:lang="en">Zamorano JL, Lancellotti P, Rodriguez Muñoz D et al. 2016 ESC Position Paper on cancer treatment and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J 2016; 37: 2768-801.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Тюляндин С.А., Виценя М.В. и др. Руководство по диагностике, профилактике и лечению сердечно-сосудистых осложнений противоопухолевой терапии. Часть I. Системные гипертензии. 2017; 14 (3): 6-20.</mixed-citation><mixed-citation xml:lang="en">Чазова И.Е., Тюляндин С.А., Виценя М.В. и др. Руководство по диагностике, профилактике и лечению сердечно-сосудистых осложнений противоопухолевой терапии. Часть I. Системные гипертензии. 2017; 14 (3): 6-20.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Curigliano G еt al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol 2020; 31: 171-90.</mixed-citation><mixed-citation xml:lang="en">Curigliano G еt al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol 2020; 31: 171-90.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Жернакова Ю.В., Ощепкова Е.В. и др. Распространенность факторов риска сердечно-сосудистых заболеваний в российской популяции больных артериальной гипертонией. Кардиология. 2014; 10: 4-12.</mixed-citation><mixed-citation xml:lang="en">Чазова И.Е., Жернакова Ю.В., Ощепкова Е.В. и др. Распространенность факторов риска сердечно-сосудистых заболеваний в российской популяции больных артериальной гипертонией. Кардиология. 2014; 10: 4-12.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Curigliano G, Cardinale D, Dent S et al. Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management. CA Cancer J Clin 2016; 66: 309-25.</mixed-citation><mixed-citation xml:lang="en">Curigliano G, Cardinale D, Dent S et al. Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management. CA Cancer J Clin 2016; 66: 309-25.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ranpura V, Pulipati B, Chu D et al. Increase risk of high-grade hypertension with bevacizumab in cancer patients: a meta-analysis. Am J Hypertens 2010; 23 (5): 460-8.</mixed-citation><mixed-citation xml:lang="en">Ranpura V, Pulipati B, Chu D et al. Increase risk of high-grade hypertension with bevacizumab in cancer patients: a meta-analysis. Am J Hypertens 2010; 23 (5): 460-8.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Авалян А.А., Ощепкова Е.В., Саидова М.А. и др. Оценка субклинической кардиотоксичности антрациклинсодержащей химиотерапии рака молочной железы в зависимости от кумулятивной дозы доксорубицина и исходного уровня артериального давления. Системные гипертензии. 2018; 15 (4): 59-64.</mixed-citation><mixed-citation xml:lang="en">Авалян А.А., Ощепкова Е.В., Саидова М.А. и др. Оценка субклинической кардиотоксичности антрациклинсодержащей химиотерапии рака молочной железы в зависимости от кумулятивной дозы доксорубицина и исходного уровня артериального давления. Системные гипертензии. 2018; 15 (4): 59-64.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mondillo S, Galderisi M, Mele D et al. Speckle-Tracking Echocardiography: A New Technique for Assessing Myocardial Function. J Ultrasound Med 2011; 30: 71-8.</mixed-citation><mixed-citation xml:lang="en">Mondillo S, Galderisi M, Mele D et al. Speckle-Tracking Echocardiography: A New Technique for Assessing Myocardial Function. J Ultrasound Med 2011; 30: 71-8.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ciro Santorol et al. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancerpatients: a balance with feasibility. Eur Heart J Cardiovasc Imag 2017; p. 1-7.</mixed-citation><mixed-citation xml:lang="en">Ciro Santorol et al. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancerpatients: a balance with feasibility. Eur Heart J Cardiovasc Imag 2017; p. 1-7.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Fei-Yan Song, Jing Shi, Ye Guo et al. Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy. Int J Cardiovasc Imag 2017; 33 (6): 857-68.</mixed-citation><mixed-citation xml:lang="en">Fei-Yan Song, Jing Shi, Ye Guo et al. Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy. Int J Cardiovasc Imag 2017; 33 (6): 857-68.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Jemal A, Ward E, Hao Y et al. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005; 294: 1255-9.</mixed-citation><mixed-citation xml:lang="en">Jemal A, Ward E, Hao Y et al. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005; 294: 1255-9.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Dorosz JL, Lezotte DC, Weitzenkamp DA et al. Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis. J Am Coll Cardiol 2012; 59 (20): 1799-808.</mixed-citation><mixed-citation xml:lang="en">Dorosz JL, Lezotte DC, Weitzenkamp DA et al. Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis. J Am Coll Cardiol 2012; 59 (20): 1799-808.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Cardinale D, Colombo A, Lamantia G et al. Anthracycline-induced cardiomyopathy: Clinical relevance and response to pharmacologic therapy. JACC 2010; 55 (3): 213-20.</mixed-citation><mixed-citation xml:lang="en">Cardinale D, Colombo A, Lamantia G et al. Anthracycline-induced cardiomyopathy: Clinical relevance and response to pharmacologic therapy. JACC 2010; 55 (3): 213-20.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kleijn SA, Aly MF, Terwee CB et al. O. Three-dimensional speckle tracking echocardiography for automatic assessment of global and regional left ventricular function based on area strain. J Am Soc Echocardiogr 2011; 24: 314-21.</mixed-citation><mixed-citation xml:lang="en">Kleijn SA, Aly MF, Terwee CB et al. O. Three-dimensional speckle tracking echocardiography for automatic assessment of global and regional left ventricular function based on area strain. J Am Soc Echocardiogr 2011; 24: 314-21.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Chen J et al. Early Detection of Cardiotoxicity by 3D Speckle Tracking Imaging of Area Strain in Breast Cancer Patients Receiving Chemotherapy. Еchocardiography 2019; 36 (9): 1682-8. DOI: 10.1111/echo.14467</mixed-citation><mixed-citation xml:lang="en">Chen J et al. Early Detection of Cardiotoxicity by 3D Speckle Tracking Imaging of Area Strain in Breast Cancer Patients Receiving Chemotherapy. Еchocardiography 2019; 36 (9): 1682-8. DOI: 10.1111/echo.14467</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Reant P, Barbot L, Touche C et al. Evaluation of global left ventricular systolic function using three-dimensional echocardiography speckle-tracking strain parameters. J Am Soc Echocardiogr 2011; 25 (1): 68-79.</mixed-citation><mixed-citation xml:lang="en">Reant P, Barbot L, Touche C et al. Evaluation of global left ventricular systolic function using three-dimensional echocardiography speckle-tracking strain parameters. J Am Soc Echocardiogr 2011; 25 (1): 68-79.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Gregorova Z, Meluzin J, Stepanova R. Longitudinal, circumferential and radial systolic left ventricular function in patients with heart failure and preserved ejection fraction. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2016; 160 (3): 385-92.</mixed-citation><mixed-citation xml:lang="en">Gregorova Z, Meluzin J, Stepanova R. Longitudinal, circumferential and radial systolic left ventricular function in patients with heart failure and preserved ejection fraction. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2016; 160 (3): 385-92.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
